Acceleron Pharma Inc is a biopharmaceutical company that focuses on developing drugs for rare diseases. MRK stock surges from September 28, it was trading at $72.72 to $75.80. Merck will acquire Acceleron for about $180 per share in cash, a premium of about 2.6% to the company’s closing price on Wednesday. Acceleron is a biopharmaceutical company focused on the discovery and development of novel medicines for treating blood-related disorders.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.